Institutional investors hold a majority ownership of CELG through the 82.61% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 808.6 Thousand shares of Celgene
SEI INVESTMENTS MANAGEMENT CORP. Bought 327.3 Thousand shares of Celgene
BOSTON ADVISORS LLC Bought 259.8 Thousand shares of Celgene